Saturday - April 27, 2024

Category Archives: Health & Medicine

Lizhuo Pharmaceutical Has Focused on the Research And Development of Pharmaceutical Intermediates

Since its establishment, Lizhuo Pharmaceutical has focused on the research and development of pharmaceutical intermediates, mainly developing and producing anti-tumor, psychotropic, antiviral, hypoglycemic and antibacterial pharmaceutical intermediates. Our company will also develop innovative drug intermediates according to the situation of … Continue reading →

Axillary Hyperhidrosis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH

The Axillary Hyperhidrosis Market Forecast report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the 7MM. DelveInsight’s “Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers … Continue reading →

Bullous Pemphigoid Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | AstraZeneca, AKARI Therapeutics, Regeneron Pharma, Argenx

The Bullous Pemphigoid Market Forecast report offers an in-depth understanding of the Bullous Pemphigoid, historical and forecasted epidemiology as well as the Bullous Pemphigoid market trends in the 7MM. The Bullous Pemphigoid market is expected to surge due to the … Continue reading →

PCSK9 Inhibitors Market to Witness Upsurge in Growth During Forecast Period (2024-2034), Examine DelveInsight | Sirnaomics, Vaxxinity, Verve Therapeutics, Xinlitai Biotech, Novo Nordisk, AstraZeneca

The PCSK9 Inhibitors Market Forecast report offers an in-depth understanding of the PCSK9 Inhibitors, historical and forecasted epidemiology as well as the PCSK9 Inhibitors market trends in the 7MM. DelveInsight’s “PCSK9 Inhibitors Market Size, Target Population, Competitive Landscape & Market … Continue reading →

Janus Kinase (JAK) Inhibitors Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Aclaris Therapeutics, Pfizer, EQRx, Celon Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Janus Kinase (JAK) Inhibitors pipeline constitutes key companies continuously working towards developing Janus Kinase (JAK) Inhibitors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Burns Pipeline and Clinical Trials Assessment, 2024 Updates: FDA Approvals, Therapies and Key Companies involved by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Burns pipeline constitutes 12+ key companies continuously working towards developing 12+ Burns treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The … Continue reading →

Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Escient Pharma, GlaxoSmithKline, Mirum Pharma, Albireo, Regeneron Pharma

The Cholestatic Pruritus Market Forecast report offers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the 7MM. Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period … Continue reading →